ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
A selective low-dose cisplatin strategy enabled by melatonin and cannabinoids for targeting osteosarcoma and chondrosarcoma.
Davut Aydın et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.